Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
METHOD FOR PRODUCING MULTISPECIFIC ANTIGEN-BINDING MOLECULES
Document Type and Number:
WIPO Patent Application WO/2021/201087
Kind Code:
A1
Abstract:
Multispecific antigen-binding molecule capable of binding to multiple different antigens, but do not non-specifically crosslink two or more immune cells such as T cells are provided. Methods for producing or enriching a preferred structural form of such multispecific antibody protein, and method for eliminating disulfide heterogeneity of such multispecific antibody proteins are provided. In addition, conformation-specific antibodies that specifically recognize the preferred form of multispecific antibody proteins, and use of the conformation-specific antibodies are provided.

Inventors:
CHICHILI VISHNU PRIYANKA REDDY (SG)
PANG CHAI LING (SG)
KAWA TATSUYA (JP)
FENG SHU (SG)
GAN SIOK WAN (SG)
TAKAHASHI NORIYUKI (SG)
MURAOKA MASARU (JP)
Application Number:
PCT/JP2021/013795
Publication Date:
October 07, 2021
Filing Date:
March 31, 2021
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
CHUGAI PHARMACEUTICAL CO LTD (JP)
International Classes:
C07K16/46; C07K1/113; C07K16/28; C12N15/13
Domestic Patent References:
WO2012064792A22012-05-18
WO2019111871A12019-06-13
WO2006047340A22006-05-04
WO2013055958A12013-04-18
WO2020027330A12020-02-06
WO2019131988A12019-07-04
WO2020067399A12020-04-02
WO2020067419A12020-04-02
WO2015156268A12015-10-15
WO2014116846A22014-07-31
WO2019131988A12019-07-04
WO2011093097A12011-08-04
WO2013126746A22013-08-29
WO1993016185A21993-08-19
WO1993001161A11993-01-21
WO1988001649A11988-03-10
WO2006132352A12006-12-14
WO2009011941A22009-01-22
WO2004092219A22004-10-28
WO2000042072A22000-07-20
WO2006106905A12006-10-12
WO2011028952A12011-03-10
WO2014018572A22014-01-30
WO2008119353A12008-10-09
WO2011131746A22011-10-27
WO2012058768A12012-05-10
WO2013063702A12013-05-10
WO2012023053A22012-02-23
WO2007114325A12007-10-11
WO1998050431A21998-11-12
WO1995033844A11995-12-14
WO2016098356A12016-06-23
WO2019111871A12019-06-13
Foreign References:
EP3070168A12016-09-21
EP3219724A12017-09-20
US20050161399A12005-07-28
US20060194280A12006-08-31
US4816567A1989-03-28
US5648237A1997-07-15
US5789199A1998-08-04
US5840523A1998-11-24
US5959177A1999-09-28
US6040498A2000-03-21
US6420548B12002-07-16
US7125978B12006-10-24
US6417429B12002-07-09
US5571894A1996-11-05
US5587458A1996-12-24
US5869046A1999-02-09
EP0404097A21990-12-27
US6248516B12001-06-19
US4946778A1990-08-07
US5260203A1993-11-09
US5731168A1998-03-24
US7695936B22010-04-13
Other References:
NAT. BIOTECHNOL., vol. 23, 2005, pages 1073 - 1078
PORTER, N ENGL J MED, vol. 365, 2011, pages 725 - 733
DUBROT, CANCER IMMUNOL. IMMUNOTHER., vol. 28, 2010, pages 512 - 22
SCHABOWSKY, VACCINE, vol. 28, 2009, pages 512 - 22
LI, PROC NATL ACAD SCI USA., vol. 110, no. 48, 2013, pages 19501 - 6
NATURE, vol. 314, no. 6012, 18 April 1985 (1985-04-18), pages 628 - 31
INT J CANCER., vol. 41, no. 4, 15 April 1988 (1988-04-15), pages 609 - 15
PROC NATL ACAD SCI USA., vol. 83, no. 5, March 1986 (1986-03-01), pages 1453 - 7
PROC NATL ACAD SCI USA., vol. 92, no. 15, 18 July 1995 (1995-07-18), pages 7021 - 5
DRUG DISCOV TODAY., vol. 10, no. 18, 15 September 2005 (2005-09-15), pages 1237 - 44
INT J CANCER., vol. 100, no. 6, 20 August 2002 (2002-08-20), pages 690 - 7
CANCER IMMUNOL IMMUNOTHER, vol. 56, no. 10, 2007, pages 1637 - 44
CANCER IMMUNOL IMMUNOTHER., vol. 55, no. 5, 2006, pages 503 - 14
CANCER IMMUNOL IMMUNOTHER., vol. 58, no. 1, 2009, pages 95 - 109
NAT REV DRUG DISCOV., vol. 13, no. 11, November 2014 (2014-11-01), pages 799 - 801
VINAY, CELLULAR & MOLECULAR IMMUNOLOGY, vol. 8, 2011, pages 281 - 284
HOUOT, BLOOD, vol. 114, 2009, pages 3431 - 8
SHIELDS ET AL., J. BIOL. CHEM., vol. 9, no. 2, 2001, pages 6591 - 6604
PROC. NATL. ACAD. SCI. U.S.A., vol. 100, no. 11, 2003, pages 6353 - 6357
BREKKE ET AL., IMMUNOL, 1995
CHOTHIALESK, J. MOL. BIOL., vol. 196, 1987, pages 901 - 917
"Oligonucleotide Synthesis", 1984
J. P. MATHERP.E. ROBERTS: "Introduction to Cell and Tissue Culture", 1998, ACADEMIC PRESS
PORTOLANO ET AL., J. IMMUNOL., vol. 150, 1993, pages 880 - 887
JOURNAL OF IMMUNOLOGY, vol. 152, no. 11, 1994, pages 5368 - 5374
PERCZEL ET AL., PROTEIN ENGRG, vol. 4, 1991, pages 669 - 679
ST JOHN ET AL., PROC NATL ACAD SCI USA, vol. 96, 1999, pages 13029 - 13033
PRESTA ET AL., CANCER RES., vol. 57, 1997, pages 4593 - 4599
SCIENCE, vol. 240, no. 4855, 1988, pages 1038 - 1041
"Monoclonal Antibodies: A Practical Approach", 2000, OXFORD UNIVERSITY PRESS
KUNKEL, PROC. NATL. ACAD. SCI. USA, vol. 82, 1985, pages 488 - 492
ANNU REV. BIOPHYS. BIOMOL. STRUCT., vol. 35, 2006, pages 225 - 249
HUDSON ET AL., NAT MED, vol. 248, 2003, pages 129 - 134
GERNGROSS, NAT. BIOTECH., vol. 22, 2004, pages 1409 - 1414
LI ET AL., NAT. BIOTECH., vol. 24, pages 210 - 215
GRAHAM ET AL., J. GEN VIROL., vol. 36, 1977, pages 59
MATHER, BIOL. REPROD., vol. 23, 1980, pages 243 - 251
MATHER ET AL., ANNALS N.Y. ACAD. SCI., vol. 383, 1982, pages 44 - 68
URLAUB ET AL., PROC. NATL. ACAD. SCI. USA, vol. 77, 1980, pages 4216
JOURNAL OF PHARMACEUTICAL SCIENCES, vol. 97, 2008, pages 2426 - 2447
ANALYTICAL BIOCHEMISTRY, vol. 348, 2006, pages 24 - 39
SEEFELDT ET AL., PROTEIN SCI, vol. 13, 2004, pages 2639 - 2650
J. RHEUMATOL, vol. 34, 2007, pages 11
CLARKSON ET AL., NATURE, vol. 352, 1991, pages 624 - 628
RAVETCHKINET, ANNU. REV. IMMUNOL, vol. 1-3, 1991, pages 457 - 92
MACCALLUM ET AL., J. MOL. BIOL., vol. 262, 1996, pages 732 - 745
BMC RESEARCH NOTES, vol. 4, 2011, pages 281
PROC. NATL. ACAD. SCI. USA, vol. 103, no. 11, 2006, pages 4005 - 4010
CHEN ET AL., J. MOL. BIOL., vol. 293, 1999, pages 865 - 881
HOLLINGER ET AL., PROC NATL ACAD SCI USA, vol. 90, 1993, pages 6444 - 6448
PROC. NATL. ACAD. SCI. U.S.A., vol. 85, no. 16, 1988, pages 5879 - 5883
J IMMUNOL. METHODS, vol. 231, no. 1-2, 1999, pages 177 - 189
PROTEIN ENGINEERING, vol. 9, no. 3, 1996, pages 299 - 305
HUM. ANTIBOD. HYBRIDOMAS, vol. 1, no. 1, 1990, pages 47 - 54
BLOOD, vol. 109, 2007, pages 1185 - 1192
DAERON, IMMUNOL., vol. 15, 1997, pages 203 - 234
CAPEL ET AL., IMMUNOMETHODS, vol. 4, 1994, pages 25 - 34
DE HAAS ET AL., J. LAB. CLIN. MED., vol. 126, 1995, pages 330 - 41
GUYER ET AL., J. IMMUNOL., vol. 117, 1976, pages 587
KIM ET AL., J. IMMUNOL., vol. 24, 1994, pages 249
GHETIEWARD, IMMUNOL. TODAY, vol. 18, no. 12, 1997, pages 592 - 598
GHETIE ET AL., NATURE BIOTECHNOLOGY, vol. 15, no. 7, 1997, pages 637 - 640
HINTON ET AL., J. BIOL. CHEM., vol. 279, no. 8, 2004, pages 6213 - 6216
DAVIS ET AL., IMMUNOLOGICAL REVIEWS, vol. 190, 2002, pages 123 - 136
RIDGWAY ET AL., PROT ENG, vol. 9, 1996, pages 617 - 621
CARTER, J IMMUNOL METH, vol. 248, 2001, pages 7 - 15
CARTER, J IMMUNOL METHODS, vol. 248, 2001, pages 7 - 15
PROTEIN ENGINEERING DESIGN & SELECTION, vol. 23, 2010, pages 195 - 202
NAT BIOTECHNOL., vol. 32, no. 2, February 2014 (2014-02-01), pages 191 - 8
CHRISTOPH ET AL., NATURE BIOTECHNOLOGY, vol. 31, 2013, pages 753 - 758
THERIEN AGGRANT FEDEBER CM: "Interhelical hydrogen bonds in the CFTR membrane domain", NAT STRUCT BIOL, vol. 8, 2001, pages 597 - 601
PROTEIN SCIENCE, vol. 4, 1995, pages 2411 - 2423
See also references of EP 4126970A4
Attorney, Agent or Firm:
HARUNA, Masao et al. (JP)
Download PDF: